← Back to Search

ICA-CHAMP: Indo-Central Asian Cardiovascular Health Assessment and Management Program (ICA-CHAMP Trial)

N/A
Waitlist Available
Led By Charlotte - Jones, PhD, MD
Research Sponsored by University of Calgary
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 5 years
Awards & highlights
No Placebo-Only Group

Summary

Research has shown that the presence of heart disease and stroke is higher in the Indo-Asian population compared to other ethno-cultural groups. This may be due to multiple reasons such as a higher presence of diabetes, high blood pressure, high cholesterol, obesity, and lower levels of physical activity. This program will bring together the Calgary Indo-Central-Asian communities and the Calgary Healthcare community to help reduce the rate of heart disease and stroke through a supportive, culturally-sensitive program that is community-based through the following steps: 1. Increase awareness of heart disease and stroke through education among the Calgary Indo-Central-Asian population. 2. Identify early, the risk factors related to heart disease and stroke through screening programs. 3. Provide appropriate follow-up care to the population at risk for heart disease and stroke.

Eligible Conditions
  • Cardiovascular Disease
  • High Cholesterol
  • High Blood Pressure

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 5 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 5 years for reporting.

Treatment Details

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Group I: 2Experimental Treatment1 Intervention
low to moderate risk
Group II: 1Experimental Treatment1 Intervention
high risk

Find a Location

Who is running the clinical trial?

University of CalgaryLead Sponsor
810 Previous Clinical Trials
885,919 Total Patients Enrolled
PfizerIndustry Sponsor
4,671 Previous Clinical Trials
17,826,660 Total Patients Enrolled
Charlotte - Jones, PhD, MDPrincipal InvestigatorUniversity of Calgary
~20 spots leftby Dec 2025